[HTML][HTML] Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment
AE Burnett, CE Mahan, SR Vazquez, LB Oertel… - Journal of thrombosis …, 2016 - Springer
Venous thromboembolism (VTE) is a serious medical condition associated with significant
morbidity and mortality, and an incidence that is expected to double in the next forty years …
morbidity and mortality, and an incidence that is expected to double in the next forty years …
[HTML][HTML] Drug–drug interactions with direct oral anticoagulants
KI Foerster, S Hermann, G Mikus, WE Haefeli - Clinical Pharmacokinetics, 2020 - Springer
A large body of evidence suggests that not only direct anticoagulant effects but also major
bleeding events and stroke prevention depend on plasma concentrations of direct oral …
bleeding events and stroke prevention depend on plasma concentrations of direct oral …
Association between use of non–vitamin K oral anticoagulants with and without concurrent medications and risk of major bleeding in nonvalvular atrial fibrillation
Importance Non–vitamin K oral anticoagulants (NOACs) are commonly prescribed with other
medications that share metabolic pathways that may increase major bleeding risk. Objective …
medications that share metabolic pathways that may increase major bleeding risk. Objective …
[HTML][HTML] 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation
CE Chiang, K Okumura, S Zhang, TF Chao, CW Siu… - Journal of arrhythmia, 2017 - Elsevier
Atrial fibrillation (AF) is the most common sustained arrhythmia, causing a 2-fold increase in
mortality and a 5-fold increase in stroke. The Asian population is rapidly aging, and in 2050 …
mortality and a 5-fold increase in stroke. The Asian population is rapidly aging, and in 2050 …
[HTML][HTML] Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin
I Gouin‐Thibault, X Delavenne, A Blanchard… - Journal of Thrombosis …, 2017 - Elsevier
Essentials• Rivaroxaban and dabigatran are substrates of the P‐glycoprotein (P‐gp)
encoded by the ABCB1 gene.• We tested the effect of ABCB1 polymorphisms and of a P‐gp …
encoded by the ABCB1 gene.• We tested the effect of ABCB1 polymorphisms and of a P‐gp …
[HTML][HTML] The Significance of drug—Drug and drug—Food interactions of oral anticoagulation
P Vranckx, M Valgimigli… - … & electrophysiology review, 2018 - ncbi.nlm.nih.gov
Vitamin K antagonists (VKAs) such as warfarin are the most commonly prescribed oral
anticoagulants worldwide. However, factors affecting the pharmacokinetics of VKAs, such as …
anticoagulants worldwide. However, factors affecting the pharmacokinetics of VKAs, such as …
Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3A
T Prueksaritanont, DA Tatosian, X Chu… - Clinical …, 2017 - Wiley Online Library
A microdose cocktail containing midazolam, dabigatran etexilate, pitavastatin, rosuvastatin,
and atorvastatin has been established to allow simultaneous assessment of a perpetrator …
and atorvastatin has been established to allow simultaneous assessment of a perpetrator …
Risk of hospitalization with hemorrhage among older adults taking clarithromycin vs azithromycin and direct oral anticoagulants
Importance Clarithromycin is a commonly prescribed antibiotic associated with higher levels
of direct oral anticoagulants (DOACs) in the blood, with the potential to increase the risk of …
of direct oral anticoagulants (DOACs) in the blood, with the potential to increase the risk of …
[HTML][HTML] Overview of the clinical pharmacology of ertugliflozin, a novel sodium-glucose cotransporter 2 (SGLT2) inhibitor
DJ Fediuk, G Nucci, VK Dawra, DL Cutler… - Clinical …, 2020 - Springer
Ertugliflozin, a selective inhibitor of sodium-glucose cotransporter 2 (SGLT2), is approved in
the US, EU, and other regions for the treatment of adults with type 2 diabetes mellitus …
the US, EU, and other regions for the treatment of adults with type 2 diabetes mellitus …
Clinical management of pharmacokinetic drug interactions with direct oral anticoagulants (DOACs)
MC Herink, YF Zhuo, CD Williams, TG DeLoughery - Drugs, 2019 - Springer
Compared with warfarin, the direct-acting oral anticoagulants (DOAC) have fewer
pharmacokinetic drug interactions. However, significant drug interactions do exist with …
pharmacokinetic drug interactions. However, significant drug interactions do exist with …